JavaScript‘Ήžƒuƒ‰ƒEƒU‚Å•\Ž¦‚µ‚Ä‚­‚¾‚³‚¢B
•Ÿ“‡Œ§—§ˆã‰È‘åŠwˆãŠw•”–ƒŒ‰ÈŠwuÀ
‹³ŽºÐ‰î
ƒgƒbƒvƒy[ƒW
‹³ŽºÐ‰î
‘²Œã—Տ°Œ¤CˆÄ“à
–ƒŒ‰È‚Æ‚Í
–ƒŒ‰Èˆã•åW
‹³ŽºŒfŽ¦”Â
V’…î•ñ
 
‰ˆŠv
fŽ@“à—eÐ‰î
Œ¤‹†Šˆ“®
‹ÆÑ•ñ
ƒXƒ^ƒbƒtÐ‰î
ƒJƒ“ƒtƒ@ƒ‰ƒ“ƒX
ŠÖ˜A•a‰@
‹ÆÑ•ñ



2018”N“x‹ÆÑW
bŒ´’˜b’˜‘E–󏑁bŠw‰ïEŒ¤‹†‰ïbƒVƒ“ƒ|ƒWƒEƒ€b‚»‚Ì‘¼

Œ´’˜
  1. Yoshida K, Isosu T, Imaizumi T, Oishi R, Obara S, Ikegami Y, Kurosawa S, Murakawa M. A case of takotsubo cardiomyopathy associated with subarachnoid hemorrhage presenting with echocardiographic abnormalities despite improvement in electrocardiographic abnormalities. Japanese Journal of Anesthesiology. 201806; 67(6):629-632.
  2. Obara S, Imaizumi T, Hakozaki T, Hosono A, Iseki Y, Sanbe N, Murakawa M. Evaluation of pharmacokinetic models of intravenous dexmedetomidine in sedated patients under spinal anesthesia. Journal of Anesthesia. 201802; 32(1):33-40.
  3. Ebana H, Obara S, Murakawa M. Mallory-Weiss syndrome diagnosed after tracheal extubation. Journal of Anesthesia. 201804; 32(2):305.
  4. Obara S. Dexmedetomidine as an adjuvant during general anesthesia. Journal of Anesthesia. 201806; 32(3):313-315.
  5. Obara S, Kurosawa S, Honda J, Oishi R, Iseki Y, Murakawa M. Cardiac arrest following anaphylaxis induced by sugammadex in a regional hospital. Journal of Clinical Anesthesia. 201802; 44:62-63.
  6. Yoshida K, Isosu T, Noji Y, Hasegawa M, Iseki Y, Oishi R, Imaizumi T, Sanbe N, Obara S, Murakawa M. Usefulness of oxygen reserve index (ORiTM), a new parameter of oxygenation reserve potential, for rapid sequence induction of general anesthesia. Journal of Clinical Monitoring and Computing. 201808; 32(4):687-691.
  7. Isosu T, Yoshida K, Oishi R, Imaizumi T, Iseki Y, Sanbe N, Ikegami Y, Obara S, Kurosawa S, Murakawa M. Effects of indigo carmine intravenous injection on oxygen reserve index (ORiTM) measurement. Journal of Clinical Monitoring and Computing. 201808; 32(4):693-697.
  8. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ1˜b) ŒŒ’†”Z“x‚Æ•ª•z—eÏ. LiSA. 201801; 25(1):32-37.
  9. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ2˜b) ÁŽ¸‘¬“x‚ƃNƒŠƒAƒ‰ƒ“ƒX. LiSA. 201802; 25(2):158-163.
  10. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ3˜b) ƒRƒ“ƒp[ƒgƒƒ“ƒgƒ‚ƒfƒ‹. LiSA. 201803; 25(3):272-277.
  11. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ4˜b) –ò•¨“®‘ÔƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“. LiSA. 201804; 25(4):392-397.
  12. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ5˜b) Œø‰Ê•”ˆÊ”Z“x‚Æ–ò—ÍŠw(1). LiSA. 201805; 25(5):520-524.
  13. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ6˜b) Œø‰Ê•”ˆÊ”Z“x‚Æ–ò—ÍŠw(2). LiSA. 201806; 25(6):630-634.
  14. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ7˜b) Œø‰Ê•”ˆÊ”Z“x‚Æ–ò—ÍŠw(3)@“Š—^Œo˜H‚Æke0. LiSA. 201807; 25(7):746-750.
  15. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ8˜b) target controlled infusion‚Æ—\‘ª¸“x. LiSA. 201808; 25(8):840-845.
  16. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ9˜b) –ò—ÍŠw“I‘ŠŒÝì—p. LiSA. 201809; 25(9):946-951.
  17. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ10˜b) ƒTƒCƒY‚Æ–ò•¨“®‘Ô(1). LiSA. 201810; 25(10):1060-1064.
  18. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ11˜b) TIVA‚ɂ܂‚í‚éƒgƒ‰ƒuƒ‹. LiSA. 201811; 25(11):1134-1138.
  19. ¬Œ´LŽ÷. ‚Ó‚Ÿ`‚Ü‚±KD(‘æ12˜b)(ÅI‰ñ) ƒTƒCƒY‚Æ–ò•¨“®‘Ô(2). LiSA. 201812; 25(12):1256-1261.
  20. •àV@L. yƒGƒLƒXƒp[ƒg‚ÉŠw‚ÔƒVƒ‡ƒbƒNŠÇ—‚Ì‚·‚ׂāz ƒAƒhƒoƒ“ƒX•Ò@dÇŠ³ŽÒ‚̃Vƒ‡ƒbƒNŠÇ—‚ðƒƒ“ƒ‰ƒ“ƒNƒAƒbƒv‚³‚¹‚邽‚߂Ɂ@ŠeŽíƒVƒ‡ƒbƒN‚Ì•a‘Ԑ¶—‚Æ‘ŸŠíáŠQ@ŒŒ‰t•ª•zˆÙí«ƒVƒ‡ƒbƒN@ƒAƒiƒtƒBƒ‰ƒLƒV[ƒVƒ‡ƒbƒN. ‹~‹}EW’†Ž¡—Ã. 201805; 30(3):397-405.
  21. ŒÜ\F„, ‘ºì‰ë—m, ¡ò@„, •àV@L. “–‰@‚É‚¨‚¯‚é‹CŠÇ‘}ŠÇ¢“ïÇ—á‚ÌŒŸ“¢. ‘h¶. 201804; 37(1):12-15.
  22. ‚–Ø–ƒ”ü, ¬Œ´LŽ÷, ŒÜ\F„, ‘ºì‰ë—m. p’†‚É–[ŽºƒuƒƒbƒN‚©‚çS’âŽ~‚Æ‚È‚è‘h¶‚µ‚½Ç—á. ‘h¶. 201810; 37(3):220a.
  23. ” è‹M‘å, ‘ºì‰ë—m, ŽO•”“¿Œb, ‰ÔŽRçŒb, ×–ì“Ö”V, ‘åÎ—]Žq, ¡ò@„, ¬Œ´LŽ÷, ŒÜ\F„, •àV@L. –ƒŒ‰È—Տ°ŽÀK‚É‚¨‚¯‚éƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‹³ˆç‚ƍ¡Œã‚̉ۑè‚ɂ‚¢‚Ä. ‘h¶. 201810; 37(3):241b.
  24. ’†–ì—TŽq, ‘åÎ—]Žq, ’†ì‰ë”V, ²“¡@ŒO, ŽO•”“¿Œb, ‘ºì‰ë—m. ‘ˆ«‚ÆŠ°‰ð‚ðŒJ‚è•Ô‚·”w•”’É‚ªæs‚µC”畆Çó‚̏oŒ»‚Ü‚Å7”NˆÈã‚ð—v‚µ‚½SAPHOÇŒóŒQ‚Ì1—á. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ. 201802; 25(1):20-23.
  25. ‹g“cŒ\—C, ŒÜ\F„, ¡ò@„, ‘åÎ—]Žq, ¬Œ´LŽ÷, ’rã”V_, •àV@L, ‘ºì‰ë—m. p’†‚ɐS“d}ˆÙí‚͉ü‘P‚µ‚½‚ªASƒGƒR[‚ŕlj^“®ˆÙí‚ªŽc‘¶‚µ‚Ä‚¢‚½‚­‚à–Œ‰ºoŒŒ‡•¹‚½‚±‚‚ڌ^S‹ØÇÇ—á‚Ì–ƒŒŒoŒ±. –ƒŒ. 201806; 67(6):629-632.
  26. ‰ÔŽRçŒb, ¬Œ´LŽ÷. ’ÁÃ–ò‚Ì–ò•¨“®‘Ô. —Տ°–ƒŒ. 201804; 42(4):581-589.
  27. k‘à“™l

  28. Yoshida K, Isosu T, Murakawa M. Making use of the Oxygen Reserve Index (ORiTM): a new parameter of oxygenation reserve potential. Pulmonary and Critical Care Medicine. 201803; 3(1): doi: 10.15761/PCCM.1000146 .
  29. ‘ºì‰ë—m. 11@–ƒŒŽè‹ZFÃ–¬–ƒŒ. ŽY‰È‚Æ•wl‰È. 201802; 85(2):197-201.
  30. k‚»‚Ì‘¼l

  31. Obara S. Recommendation of [Colin PJ, et al. Br J Anaesth. 2017; 119(2):200-210] Dexmedetomidine pharmacokinetic-pharmacodynamic modelling in healthy volunteers: 1. Influence of arousal on bispectral index and sedation. F1000Prime. 20180606; doi: 10.3410/f.733014790.793546492.
  32. Obara S, Imaizumi T, Hakozaki T, Hosono A, Iseki Y, Sanbe N, Murakawa M. Correction to: Evaluation of pharmacokinetic models of intravenous dexmedetomidine in sedated patients under spinal anesthesia. Journal of Anesthesia. 201804; 32(3):479.

’˜‘E–ó‘
  1. Kim TK, Obara S, Johnson KB. Chapter 4 BASIC PHARMACOLOGIC PRINCIPLES. In: Pardo MC Jr, Miller RD, editors. Basics of Anesthesia, 7th edition. Philadelphia, USA: Elsevier; 2018. p.33-52.
  2. ¬Œ´LŽ÷ –ó. Section 3 –ò—ÍŠw‚Æ–ò•¨“®‘Ô. In: ’·âˆÀŽq ŠÄ–ó. ƒOƒ‰ƒtƒBƒbƒN–ƒŒŠw@—Տ°‚ªŠy‚µ‚­‚È‚é}EŽ®E•\. “Œ‹ž: ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹; 201807. p.155-164.
  3. ¬Œ´LŽ÷ –ó. Section 4 –ò•¨. In: ’·âˆÀŽq ŠÄ–ó. ƒOƒ‰ƒtƒBƒbƒN–ƒŒŠw@—Տ°‚ªŠy‚µ‚­‚È‚é}EŽ®E•\. “Œ‹ž: ƒƒfƒBƒJƒ‹EƒTƒCƒGƒ“ƒXEƒCƒ“ƒ^[ƒiƒVƒ‡ƒiƒ‹; 201807. p.165-178.
  4. ‘ºì‰ë—m. A“ªáz¹. In: XŽR@Š° ŠÄC. ¡“ú‚ÌŽ¨•@ˆôA‰ÈE“ªèò•”ŠO‰ÈŽ¡—ÃŽwj ‘æ4”Å. “Œ‹ž: ˆãŠw‘‰@; 201806. p.435-436.
  5. ‘ºì‰ë—m. • •”ŠO‰ÈŽèp‚Ì–ƒŒ. In: ŒÃ‰Æ@m ŠÄC. •W€–ƒŒ‰ÈŠw ‘æ7”Å. “Œ‹ž: ˆãŠw‘‰@; 201803. p.222-226.
  6. ¬Œ´LŽ÷. ‘SÃ–¬–ƒŒ(TIVA), ’ÁÃ(MAC). In: ŽRˆü“¹–¾, œA“c˜a”ü ŠÄC. –ƒŒ‰ÈŠwƒŒƒrƒ…[ 2018. “Œ‹ž: ‘‡ˆãŠwŽÐ; 201803. p.150-154.
  7. ‘ºì‰ë—m. ŽèpŽºŠë‹@ŠÇ—EˆÀ‘S‘΍ô. In: ŽRˆü“¹–¾, œA“c˜a”ü ŠÄC. –ƒŒ‰ÈŠwƒŒƒrƒ…[ 2018. “Œ‹ž: ‘‡ˆãŠwŽÐ; 201803. p.155-158.

Šw‰ïEŒ¤‹†‰ï

    kŒ¤‹†”­•\l

  1. Hanayama C, Hosono A, Imaizumi T, Obara S, Isosu T, Murakawa M. Incidence and risk factors for subcutaneous emphysema during robot-assisted laparoscopic prostatectomy. Euroanaesthesia2018 The European Anaesthesiology Congress; 20180602; Copenhagen, Denmark.
  2. Yoshida K, Noji Y, Sanbe N, Ebana H, Obara S, Murakawa M. Respiratory Depression After Intraoperative Opioid-Containing Periarticular Multimodal Drug Injection. Euroanaesthesia2018 The European Anaesthesiology Congress; 20180603; Copenhagen, Denmark.
  3. Ogawa T, Obara S, Akino M, Hanayama C, Ishido H, Murakawa M. The predictive performance of propofol target-controlled infusion during CO2 pneumoperitoneumin patients in the head down position. Euroanaesthesia2018 The European Anaesthesiology Congress; 20180604; Copenhagen, Denmark.
  4. Oishi R, Obara S, Hasegawa M, Hakozaki T, Iseki Y, Murakawa M. The accuracy of noninvasive total hemoglobin measurement in critically ill patients. Euroanaesthesia2018 The European Anaesthesiology Congress; 20180604; Copenhagen, Denmark.
  5. Ebana H, Noji Y, Honda J, Oishi R, Hosono A, Murakawa M. Airway Obstruction Due To The Compression Of Tracheal Stent By Grown Upper Mediastinal Tumor. 2018 Annual Meeting American Society of Anesthesiologists; 20181013; San Francisco, USA.
  6. Ishido H, Murakawa M, Hosono A, Imaizumi T, Hanayama C, Obara S. Hyperkalemia Might Be Induced By Average Doses Of Short-term infusion Of Propofol. 2018 Annual Meeting American Society of Anesthesiologists; 20181014; San Francisco, USA.
  7. ²“¡@–¾, ŒÜ\F„, ¡ò@„, ‘ºì‰ë—m. “–‰@‚É‚¨‚¯‚é90ÎˆÈã‚Ì’´‚—îŽèpŠ³ŽÒ‚ÌŽüpŠúŠÇ—‚Æ“]‹A. ‘æ30‰ñ“ú–{˜V”N–ƒŒŠw‰ï; 20180210; ì. ƒvƒƒOƒ‰ƒ€E´˜^W. 61.
  8. ‘åÎ—]Žq, ’·’Jì^‹MŽq, ˆäÎ—YŽO, ¡ò@„, ” è‹M‘å, ¬Œ´LŽ÷, ŒÜ\F„, •àV@L, ‘ºì‰ë—m. NO‹z“ü—Ö@‚ª—LŒø‚Å‚ ‚Á‚½ARDS‚̈ê—á. ‘æ45‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï; 20180221; –‹’£. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ. 25(Supplement):140.
  9. ŽO•”“¿Œb, ‹g“cŒ\—C, ×–ì“Ö”V, ” è‹M‘å, ¬Œ´LŽ÷, Åã@‰, ’†–ì—TŽq, ŒÜ\F„, •àV@L, ‘ºì‰ë—m. Š´õ«S“à–Œ‰Š‚ɑ΂·‚é‘m–[•Ù’uŠ·pŒãÄŠJ‹¹Ž~ŒŒpŽž‚̃Cƒ_ƒ‹ƒVƒYƒ}ƒu‚Ì“Š—^ŒoŒ±. ‘æ45‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï; 20180221; –‹’£. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ. 25(Supplement):142.
  10. ™ŽR‘ñ–ç, •½–ì‹M‹K, Î“cŽž–ç, ‰¡ŽRG”V, ŒF“c–F•¶, ŽÂŒ´ˆê². ¶t“®Ã–¬‘¹‚É‚æ‚é‘å—ʌ㕠–ŒoŒŒ‚ɑ΂µ‚ÄREBOA‚ðŽg—p‚µ‹~–½‚µ‚½ˆê—á. ‘æ45‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï; 20180221; –‹’£. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ. 25(Supplement):145.
  11. –{“c@, ]‰Ô‰p˜N, ‘å‹´@’q, ” è‹M‘å, ˆäÎ—YŽO, ŽO•”“¿Œb, ŒÜ\F„, •àV@L, ‘ºì‰ë—m. ŠO‚É‚æ‚é‹}«AŒ^‘å“®–¬‰ð—£pŒã‚ɐlHS”x—£’E¢“ï‚ɊׂèLVAD‚ð‘•’…‚µ‹~–½‚µ‚½‚P—á. ‘æ45‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï; 20180222; –‹’£. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ. 25(Supplement):155.
  12. ’¹ŠC”ŽŽi, Šp’n—SK, ‘å–ì^—Žq, ‚‹´@ˆ², ‘h‰ä–ÐŒQ, ”WŒûç—¢, ŒÜ\—äL“ñ, ‹«“cN“ñ. ƒJƒtƒFƒCƒ“‘½—Ê•ž–ò‚É‚æ‚è“«SŽº×“®‚ð‚«‚½‚µAv‘¬‚ÈVA-ECMOŠm—§‚É‚æ‚è‹~–½‚µ‚¦‚½ˆê—á. ‘æ45‰ñ“ú–{W’†Ž¡—ÈãŠw‰ïŠwpW‰ï; 20180222; –‹’£. “ú–{W’†Ž¡—ÈãŠw‰ïŽGŽ. 25(Supplement):161.
  13. ‘åÎ—]Žq, ’†–ì—TŽq, ²“¡@ŒO, •àV@L, ¬”¦‰pÍ, ‘ºì‰ë—m. •›ì—p‚Ì‚½‚߃Jƒ‹ƒoƒ}ƒ[ƒsƒ“‚ð•ž—p‚Å‚«‚È‚©‚Á‚½‚ªA—}ŠÌŽU’”甼‰Ä‚ª’˜Œø‚µ‚½ŽO³_Œo’É‚Ì1—á. ‘æ42‰ñ“Œ–kƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï; 20180324; ŽRŒ`. ƒvƒƒOƒ‰ƒ€E´˜^W. 33.
  14. ’†–ì—TŽq, ‘åÎ—]Žq, ŽO•”“¿Œb, ²“¡@ŒO, ŒÜ\F„, •àV@L, ¬”¦‰pÍ, ‘ºì‰ë—m. ”DP‚ðŠó–]‚µ‚½‚½‚ߍÊïŒ`«‚Ì‚ ‚éƒoƒ‹ƒvƒŽ_‚𒆎~‚µAŠ¿•û–ò‚ŏǏó‚ðƒRƒ“ƒgƒ[ƒ‹‚µ‚½–ò•¨——p“ª’ɂ̈ê—á. ‘æ42‰ñ“Œ–kƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï; 20180324; ŽRŒ`. ƒvƒƒOƒ‰ƒ€E´˜^W. 34.
  15. ŽO•”“¿Œb, ‘åÎ—]Žq, ¬Œ´LŽ÷, •àV@L, ‘ºì‰ë—m. ‘½EŽ®ƒJƒe[ƒeƒ‹‚ð—p‚¢’°œÌŽæ•”ˆÊ‚ɑ΂µŽ‘±Z–ƒŒ‚ðs‚Á‚½Ç—á. “ú–{‹æˆæ–ƒŒŠw‰ï‘æ5‰ñŠwpW‰ï; 20180413; ‘åã. ƒvƒƒOƒ‰ƒ€E´˜^W. 124.
  16. ‘åÎ—]Žq, ŽO•”“¿Œb, •àV@L, ¬”¦‰pÍ, ‘ºì‰ë—m. d–ŒŠO–ƒŒŽ{sŽž‚ɃJƒe[ƒeƒ‹‚ª–TÒ’ōo‚É–À“ü‚µ‚½1—á. “ú–{‹æˆæ–ƒŒŠw‰ï‘æ5‰ñŠwpW‰ï; 20180414; ‘åã. ƒvƒƒOƒ‰ƒ€E´˜^W. 161.
  17. –{“c@, ŽO•”“¿Œb, ‘åÎ—]Žq, ×–ì“Ö”V, ’†–ì—TŽq, ” ú±‹M‘å, ’·’Jì^‹MŽq, ˆäÎ—YŽO, ‰ÔŽRçŒb, ‘ºì‰ë—m. ŒÄ‹z”ƒ‚ƒjƒ^ƒŠƒ“ƒO‚É‹y‚Ú‚·•½‹Ï‰»ŽžŠÔ‚̉e‹¿. ‘æ29‰ñ“ú–{—Տ°ƒ‚ƒjƒ^[Šw‰ï‘‰ï; 20180420; ‰¡•l. —Տ°ƒ‚ƒjƒ^[. 29(Supplement):43.
  18. ‹g“cŒ\—C, ŒÜ\F„, –ì’n‘PŒb, ]‰Ô‰p˜N, –{“c@, ¡ò@„, ¬Œ´LŽ÷, •àV@L, ‘ºì‰ë—m. V‚µ‚¢Ž_‘f‰»—\”õ”\‚̃pƒ‰ƒ[ƒ^‚Å‚ ‚éOxygen Reserve Index(ORiTMj‚ð—˜—p‚µ‚½‘Sg–ƒŒ’†‚Ì‹z“üŽ_‘f”Z“x‚Ì’²®‚ɂ‚¢‚Ä. ‘æ29‰ñ“ú–{—Տ°ƒ‚ƒjƒ^[Šw‰ï‘‰ï; 20180420; ‰¡•l. —Տ°ƒ‚ƒjƒ^[. 29(Supplement):47.
  19. ¯–ì@ˆê, œA–Ø’‰’¼, âV“¡@”É, ‘ºì‰ë—m, ¬”¦‰pÍ. ƒ‰ƒbƒg_ŒoáŠQ«áu’Ƀ‚ƒfƒ‹‚ð—p‚¢‚½NaSSA‚¨‚æ‚ÑSNRI‚Ì’Á’É‹@˜‚ÌŒŸ“¢. “ú–{–ƒŒ‰ÈŠw‰ï‘æ65‰ñŠwpW‰ï; 20180517; ‰¡•l. –ƒŒ. 67(—ÕŽž‘Š§):95.
  20. ŽÂŒ´ˆê², ç“cN”V, ™ŽR‘ñ–ç, Î“cŽž–ç, ‰¡ŽRG”V, ŒF“c–F•¶. ŽÔ—¼‰^“]’†‚̈ӎ¯áŠQ”­ì‚ÌŽÀ‘ԁFŒð’ÊŠOŠ³ŽÒ‚Ì–ƒŒ‚É‚¨‚¯‚épitfall. “ú–{–ƒŒ‰ÈŠw‰ï‘æ65‰ñŠwpW‰ï; 20180517; ‰¡•l. –ƒŒ. 67(—ÕŽž‘Š§):107.
  21. ‘å’ǝŒb, “‡’×EŽO, ×–ì“Ö”V, •ž•”®Žm, ¬¼W¶, ŠÇ@Œjˆê. • o‹¾‰º‘å’°ŽèpŒã‚Ì’Á’É‚É‚¨‚¯‚é‹ÇŠZ–ƒŒ‚Æ’´‰¹”gƒKƒCƒh‰º_ŒoƒuƒƒbƒN‚Ì”äŠr. “ú–{–ƒŒ‰ÈŠw‰ï‘æ65‰ñŠwpW‰ï; 20180518; ‰¡•l. –ƒŒ. 67(—ÕŽž‘Š§):100.
  22. ûü–Ø–ƒ”ü, ‘åÎ—]Žq, Î“°‰l”ü, ŽO•”“¿Œb, ’†–ì—TŽq, ‘ºì‰ë—m. ”\“®‹i‰Œ‚Ü‚½‚ÍŽó“®‹i‰Œ‚É‚æ‚épŒã‡•¹Ç‚Ì”­Ç—¦. “ú–{–ƒŒ‰ÈŠw‰ï‘æ65‰ñŠwpW‰ï; 20180518; ‰¡•l. –ƒŒ. 67(—ÕŽž‘Š§):114.
  23. ²“¡—D‹I, ¬ì½Žq, –{“c@, ×–ì“Ö”V, ¬Œ´LŽ÷, •àV@L. ƒJƒ‹ƒVƒEƒ€hR–ò‚ðŠÜ—L‚·‚é”z‡ù‚Ì’†Ž~‚É‚æ‚é‘Sg–ƒŒŽž‚ÌŒŒˆ³‚É‹y‚Ú‚·‰e‹¿. “ú–{–ƒŒ‰ÈŠw‰ï‘æ65‰ñŠwpW‰ï; 20180517; ‰¡•l. –ƒŒ. 67(—ÕŽž‘Š§):115.
  24. ¬Œ´LŽ÷, ‰ÔŽRçŒb, –ì’n‘PŒb, ûü–Ø–ƒ”ü, •àV@L, ‘ºì‰ë—m. ŽèpŽºŠÅŒìŽt‚É‚¨‚¯‚éŽèp‹Æ–±‚ÆŠ´î˜J“­‚Æ‚ÌŠÖŒW. •Ÿ“‡ˆãŠw‰ï‘æ470‰ñŠwpŒ¤‹†W‰ï; 20180524; •Ÿ“‡. •Ÿ“‡ˆãŠwŽGŽ. 68(3):235.
  25. ²“¡@ŒO, ¼’ˁ@’, “¡–{‡Žq, ‘ºì‰ë—m. ƒƒTƒhƒ“‚ªŒ´ˆö‚ƍl‚¦‚ç‚ê‚éƒAƒJƒVƒWƒA‚𐶂¶‚½ˆêÇ—á. ‘æ23‰ñ“ú–{ŠÉ˜aˆã—Êw‰ïŠwp‘å‰ï; 20180615; _ŒË. ƒvƒƒOƒ‰ƒ€. S74.
  26. ¬Œ´LŽ÷, ‘åÎ—]Žq, ŒÜ\F„, ‘ºì‰ë—m. Ò‘‚­‚à–Œ‰º–ƒŒ’†Š³ŽÒ‚É‚¨‚¯‚éƒfƒNƒXƒƒfƒgƒ~ƒWƒ“Œø‰Ê•”ˆÊ”Z“xƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‚̐¸“xŒŸØ. ‘æ22‰ñ“ú–{_Œo–ƒŒW’†Ž¡—Êw‰ï; 20180623; ‚è. ƒvƒƒOƒ‰ƒ€E´˜^W. 48.
  27. ‘åÎ—]Žq, ¬Œ´LŽ÷, ŒÜ\F„, ‘ºì‰ë—m. ŠoÁ‰º“ªŠW“àŽîᇓEop‚É‚¨‚¯‚鎨‰î‘¤“ª_ŒoƒuƒƒbƒN‚Ì•û–@‚ÌŒŸ“¢. ‘æ22‰ñ“ú–{_Œo–ƒŒW’†Ž¡—Êw‰ï; 20180623; ‚è. ƒvƒƒOƒ‰ƒ€E´˜^W. 52.
  28. ]‰Ô‰p˜N, ˆäÎ—YŽO, ” ú±‹M‘å, ¬Œ´LŽ÷, ŒÜ\F„, ‘ºì‰ë—m. ãcŠuŽîᇂɑ΂·‚é‹CŠÇƒXƒeƒ“ƒg—¯’upŒã‚ɁA‹C“¹‚̍ċ·ó‚É‚æ‚é‹}«ŒÄ‹z•s‘S‚ð’悵‚½1—á. “ú–{W’†Ž¡—ÈãŠw‰ï‘æ2‰ñ“Œ–kŽx•”ŠwpW‰ï; 20180707; ·‰ª. ƒvƒƒOƒ‰ƒ€E´˜^W. 37.
  29. ²“¡@ŒO, ’†–ì—TŽq, ‘åÎ—]Žq, ¬”¦‰pÍ, ‘ºì‰ë—m. ’¼’°‚ª‚ñÄ”­ŽîᇓEoŒã‚̓«áu’É‚É‹Ø–ŒƒŠƒŠ[ƒX’ŽË‚ª’˜Œø‚µ‚½ˆê—á. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ52‰ñ‘å‰ï; 20180720; “Œ‹ž. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ. 25(3):159.
  30. ’†–ì—TŽq, ‘åÎ—]Žq, ŽO•”“¿Œb, ²“¡@ŒO, ŒÜ\F„, •àV@L, ‘ºì‰ë—m. ƒgƒ‰ƒ€ƒZƒbƒg®‚É‚æ‚郏ƒ‹ƒtƒ@ƒŠƒ“‚̍ì—p‘‹­‚ð‚«‚½‚µ‚½¸‘ƒŽîᇉ»Šw—Ö@ŒããŽˆ’ɂ̈ê—á. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ52‰ñ‘å‰ï; 20180721; “Œ‹ž. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ. 25(3):168.
  31. ¬—ї批, ˆÀ•”—mˆê˜Y, ã“‡Œ«Æ, ’†ì‰ë”V, ‰|”¨@‹ž, –k‘ºr•½. NRS‚ÆShort-Form McGill Pain Questionnaire 2‚ÌŠÖŒW. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ52‰ñ‘å‰ï; 20180720; “Œ‹ž. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ. 25(3):O1-3.
  32. “‚àV—S‹P, ‰|”¨@‹ž, _è³l, ã“‡Œ«Æ, ’†ì‰ë”V, —с@–€–ë, –k‘ºr•½, ˆÀ•”—mˆê˜Y. ‚؃Cƒ“ƒNƒŠƒjƒbƒN‰ŠwŽÒ‚Ì’´‰¹”g•`o—ÍŒüã‚ɑ΂·‚éŽæ‚è‘g‚Ý. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ52‰ñ‘å‰ï; 20180720; “Œ‹ž. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ. 25(3):O5-3.
  33. Î”öƒˆê, ’†ì‰ë”V, ŽR“cŽõ•F, —с@–€–ë, –k‘ºr•½, ‰|”¨@‹ž, ã“‡Œ«Æ, ˆÀ•”—mˆê˜Y. “–‰@‚Å‚ÌŒo”ç“I’ŊԔ‘Šj“Eop‚ÌŽ¡—ÃŒø‰Ê‚Æ“K‰ž‚ÌŒŸ“¢‚Ɖ”\«. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ52‰ñ‘å‰ï; 20180721; “Œ‹ž. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ. 25(3):O7-7.
  34. _è³l, ‰|”¨@‹ž, “‚àV—S‹P, –k‘ºr•½, —с@–€–ë, ’†ì‰ë”V, ã“‡Œ«Æ, ˆÀ•”—mˆê˜Y. ’·Šú‚ɂ킽‚éTonicŽhŒƒŽg—pŒãABurstDRTMŽhŒƒ‚ɕύX‚µ‚½6Ç—á‚ÌŽ¡—ÃŒoŒ±. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ52‰ñ‘å‰ï; 20180721; “Œ‹ž. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ. 25(3):O9-5.
  35. ŽR“cŽõ•F, Î”öƒˆê, —с@–€–ë, ’†ì‰ë”V, –k‘ºr•½, ‰|”¨@‹ž, ã“‡Œ«Æ, ˆÀ•”—mˆê˜Y. “–‰@‚ł̉ï‰A’É‚ÌŽ¡—ЬÑ. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ52‰ñ‘å‰ï; 20180720; “Œ‹ž. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ. 25(3):P1-25.
  36. –k‘ºr•½, ã“‡Œ«Æ, •s”j—ç”ü, ¬—ї批, ‰|”¨@‹ž, —с@–€–ë, ’†ì‰ë”V, ˆÀ•”—mˆê˜Y. “–‰È‚̐_ŒoƒuƒƒbƒN—Ö@‚ðŽå‘Ì‚Æ‚µ‚½Ž¡—ª–«’ɏǗá‚ÌQOL‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ52‰ñ‘å‰ï; 20180721; “Œ‹ž. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ. 25(3):P3-46.
  37. Š_–ì“àq, ˆäÎ—YŽO, –ì’n‘PŒb, ‰ÔŽRçŒb, ” ú±‹M‘å, ŒÜ\F„. ‘å“®–¬‰ð—£‚ðŒ_‹@‚É‘å“®–¬•Ù•Â½•s‘S‚𐶂¶A–«ŒÄ‹z•s‘S‚Æ‚È‚Á‚½ˆê—á. “ú–{–ƒŒ‰ÈŠw‰ï–kŠC“¹E“Œ–kŽx•”‘æ8‰ñŠwpW‰ï; 20180901; ˆ®ì. ƒvƒƒOƒ‰ƒ€W. 37.
  38. ‰““¡ç–ƒ, “‡“c‹v”ü, ŽáŒ´Žu•Û, “¡“cŠì‹v, Ô’ÃŒ«•F, ¼ìŒõˆê. A“ª”X–E‚ÌŽèp‚ɍۂµ‹C“¹Šm•Û¢“—\‘z‚³‚ꂽŠ³ŽÒ‚ɃGƒAƒEƒFƒCƒXƒR[ƒv(AWS)‚ð—p‚¢ˆÀ‘S‚ÉŠÇ—‚Å‚«‚½2Ç—á. “ú–{–ƒŒ‰ÈŠw‰ï–kŠC“¹E“Œ–kŽx•”‘æ8‰ñŠwpW‰ï; 20180901; ˆ®ì. ƒvƒƒOƒ‰ƒ€W. 38.
  39. ²“¡@–¾, ”¼àV_ˆê, “‡’×EŽO, •ž•”®Žm, ¬¼W¶, ŠÇ@Œjˆê. d–ŒŠOŽ©‰ÆŒŒ’“üŒã‚É‚­‚à–Œ‰ºoŒŒ‚ð‚«‚½‚µ‚½”]Ò‘‰t˜RoÇ‚̈ê—á. “ú–{–ƒŒ‰ÈŠw‰ï–kŠC“¹E“Œ–kŽx•”‘æ8‰ñŠwpW‰ï; 20180901; ˆ®ì. ƒvƒƒOƒ‰ƒ€. 38.
  40. ²“¡—D‹I, Z‹g”ü•ä, “n•”˜aO. Šg’£Œ^S‹ØÇ‚ð‡•¹‚µ‚½‹‘åŒã• –ŒŽîᇐ؏œp‚Ì–ƒŒŒoŒ±. “ú–{–ƒŒ‰ÈŠw‰ï–kŠC“¹E“Œ–kŽx•”‘æ8‰ñŠwpW‰ï; 20180901; ˆ®ì. ƒvƒƒOƒ‰ƒ€W. 39.
  41. Î“cŽž–ç, ŒF“c–F•¶. –ƒŒ‰Èˆã‚Ö‚Ì‘å“®–¬•Â½ƒoƒ‹[ƒ“‹³ˆç‚É‚¨‚¯‚éŽw“±ƒ|ƒCƒ“ƒg. “ú–{–ƒŒ‰ÈŠw‰ï–kŠC“¹E“Œ–kŽx•”‘æ8‰ñŠwpW‰ï; 20180901; ˆ®ì. ƒvƒƒOƒ‰ƒ€. 41.
  42. £“cì—T‹IŽq, ¬Œ´LŽ÷, “c’†ŽD, ]‰Ô‰p˜N, ¡ò@„, ‘ºì‰ë—m. ‘Sg–ƒŒ“±“üŽž‚É“´‹@”\’ቺ‚©‚獂“x™–¬‚𗈂µ‚½ˆê—á. “ú–{–ƒŒ‰ÈŠw‰ï–kŠC“¹E“Œ–kŽx•”‘æ8‰ñŠwpW‰ï; 20180901; ˆ®ì. ƒvƒƒOƒ‰ƒ€W. 41.
  43. Î“°‰l”ü, ²“¡—F•F, “‡“c‹v”ü, ŽáŒ´Žu•Û, “¡“cŠì‹v, Ô’ÃŒ«•F. Ä–c’£«”x…Žî‚Æ‘½”­«ƒuƒ‰‚ð‡•¹‚µ‚½‘±”­«‹C‹¹‚Ì–ƒŒŠÇ—. “ú–{–ƒŒ‰ÈŠw‰ï–kŠC“¹E“Œ–kŽx•”‘æ8‰ñŠwpW‰ï; 20180901; ˆ®ì. ƒvƒƒOƒ‰ƒ€W. 42.
  44. ²“¡—F•F, ‰““¡ç–ƒ, Î“°‰l”ü, “¡“cŠì‹v, Ô’ÃŒ«•F, ¼ìŒõˆê. • •”ŽèpŒãAæ“V«‹CŠÇ‹·ó‚Ɛf’f‚³‚ꂽV¶Ž™‚Ì1Ç—á. “ú–{–ƒŒ‰ÈŠw‰ï–kŠC“¹E“Œ–kŽx•”‘æ8‰ñŠwpW‰ï; 20180901; ˆ®ì. ƒvƒƒOƒ‰ƒ€W. 92.
  45. –{“c@, ]‰Ô‰p˜N, ˆäÎ—YŽO, ‘åÎ—]Žq, ” ú±‹M‘å, ¬Œ´LŽ÷. • •”‘å“®–¬áŽ‚ɑ΂·‚élHŒŒŠÇ’uŠ·p’†‚ɁA‹¹•”‰ºs‚Ì–«‘å“®–¬‰ð—£‚ª‹UoŠg‘å‚𗈂½‚µpŽ®‚ð’ljÁ‚µ‚½1—á. “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ23‰ñŠwp‘å‰ï; 20180914; “Œ‹ž. Cardiovascular Anesthesia. 22(Supplement):182.
  46. ŽO•”“¿Œb, ]‰Ô‰p˜N, ˆäÎ—YŽO, ‘åÎ—]Žq, ” ú±‹M‘å, ¬Œ´LŽ÷, –{“c@. Barlow's type‘m–[•Ù•Â½•s‘S‚ð’悵‚½—AŒŒ‹‘”ۏǗá‚ɑ΂·‚é‘m–[•Ù’uŠ·p‚Ì–ƒŒŒoŒ±. “ú–{S‘ŸŒŒŠÇ–ƒŒŠw‰ï‘æ23‰ñŠwp‘å‰ï; 20180915; “Œ‹ž. Cardiovascular Anesthesia. 22(Supplement):256.
  47. •àV@L. ‹³ˆçu‰‰1 –ƒŒŠÇ—‚ƏpŒã—\Œã‚Æ‚ÌŠÖŒW. ‘æ40‰ñ“ú–{ŽèpˆãŠw‰ï‘‰ï; 20181012; “Œ‹ž. ƒvƒƒOƒ‰ƒ€E´˜^W. 76.
  48. •“¡‚Ђë‚Ý, ²–ì—F”ü, Â–ØŒ’ˆê, ²£‚Ђë‚Ì. ”j—ô«• •”‘å“®–¬áŽ‚̏pŒãŠÇ—‚ÉäNã÷“àˆ³‘ª’肪—L—p‚Å‚ ‚Á‚½Ç—á. “ú–{—Տ°–ƒŒŠw‰ï‘æ38‰ñ‘å‰ï; 20181102; –k‹ãB. “ú–{—Տ°–ƒŒŠw‰ïŽ. 38(6):S287.
  49. ‹g‰ª‹`˜N, Î“cŽž–ç, ‰¡ŽRG”V, ŒF“c–F•¶. ‘Sg–ƒŒ“±“üŒã‚Ì‘}ŠÇ¢“ï‚ɑ΂µAAir-Q‚Æ‹CŠÇŽx‹¾‚ð—p‚¢‚Ä‹CŠÇ‘}ŠÇ‚µ‚½ˆê—á. “ú–{—Տ°–ƒŒŠw‰ï‘æ38‰ñ‘å‰ï; 20181102; –k‹ãB. “ú–{—Տ°–ƒŒŠw‰ïŽ. 38(6):S288.
  50. “c’†ÊD, ×–ì“Ö”V, –{“c@, ’†–ì—TŽq, ²“¡@ŒO, ŒÜ\F„, •àV@L, ‘ºì‰ë—m. ˜A‡•Ù–ŒÇ‚É‚æ‚éS•s‘SŠ³ŽÒ‚ɑ΂µ––½_ŒoƒuƒƒbƒN‚ÅŠÇ—‚µ‚½•Â½Eƒwƒ‹ƒjƒAC•œp‚̈ê—á. ‘æ38‰ñ“ú–{—Տ°–ƒŒŠw‰ï; 20181102; –k‹ãB. “ú–{—Տ°–ƒŒŠw‰ïŽ. 38(6):S292.
  51. ŽO•”“¿Œb, ‘ºì‰ë—m, •àV@L, ŒÜ\F„. SƒTƒ‹ƒRƒCƒh[ƒVƒX‚ª•¹‘¶‚µ‚½•@’†Šuœ^‹ÈÇ—á‚ɑ΂·‚é‘Sg–ƒŒ‚ÌŒoŒ±. ‘æ38‰ñ“ú–{—Տ°–ƒŒŠw‰ï; 20181102; –k‹ãB. “ú–{—Տ°–ƒŒŠw‰ïŽ. 38(6):S305.
  52. X—ÚŽuˆŸ, o‰H–¾Žq, ˆÀ’B@Žç. ‘яóáv]Œã_Œo’ɂɑ΂µƒpƒƒLƒZƒ`ƒ“‚ª’˜Œø‚µ‚½ˆê—á. “ú–{—Տ°–ƒŒŠw‰ï‘æ38‰ñ‘å‰ï; 20181102; –k‹ãB. “ú–{—Տ°–ƒŒŠw‰ïŽ. 38(6):S310.
  53. ŽRŒû—T“ñ, ¬¼W¶, •ž•”®Žm, “‡’×EŽO, ‘«—§‘‘å, ŠÇ@Œjˆê. ‹CŠÇ‘}ŠÇŽž‚É‚¨‚¯‚鎕‰å‘¹—\–h‚Ì‚½‚߂̃}ƒEƒXƒs[ƒX‚ÌŽŽ‚Ý. “ú–{—Տ°–ƒŒŠw‰ï‘æ38‰ñ‘å‰ï; 20181102; –k‹ãB. “ú–{—Տ°–ƒŒŠw‰ïŽ. 38(6):S316.
  54. ‘«—§‘‘å, ŠÇ@Œjˆê, •ž•”®Žm, ¬¼W¶, “‡’×EŽO. ƒ}ƒ“ƒjƒg[ƒ‹‚ÌŠÖ—^‚ª‹^‚í‚ꂽ‹}«t•s‘S‚Ì‚P—á. “ú–{—Տ°–ƒŒŠw‰ï‘æ38‰ñ‘å‰ï; 20181102; –k‹ãB. “ú–{—Տ°–ƒŒŠw‰ïŽ. 38(6):S328.
  55. –ì’n‘PŒb, ûü–Ø–ƒ”ü, ‰ÔŽRçŒb, ˆäÎ—YŽO, ” ú±‹M‘å, ŒÜ\F„, •àV@L, ‘ºì‰ë—m. ¬Ž™‚Ì”MŠ³ŽÒ‚É‚¨‚¢‚ÄŒo”ç“Iƒg[ƒ^ƒ‹ƒwƒ‚ƒOƒƒrƒ“‘ª’肪—L—p‚Å‚ ‚Á‚½ˆê—á. ‘æ38‰ñ“ú–{—Տ°–ƒŒŠw‰ï; 20181103; –k‹ãB. “ú–{—Տ°–ƒŒŠw‰ïŽ. 38(6):S346.
  56. ²–ì—F”ü, •“¡‚Ђë‚Ý, Â–ØŒ’ˆê, ²£‚Ђë‚Ì. ‘Sg–ƒŒ“±“üŒã‚ɐSŽº•p”ASŽº×“®‚𐶂¶‚½‚­‚à–Œ‰ºoŒŒ‚Ì‚P—á. “ú–{—Տ°–ƒŒŠw‰ï‘æ38‰ñ‘å‰ï; 20181103; –k‹ãB. “ú–{—Տ°–ƒŒŠw‰ïŽ. 38(6):S353.
  57. é“c‚³‚‚«, ‘åÎ—]Žq, ’·’Jì‹M”V, ]‰Ô‰p˜N, ¬Œ´LŽ÷, ŒÜ\F„, •àV@L, ‘ºì‰ë—m. ŽY‰ÈŠ³ŽÒ‚ÌŽ©ŒÈŒŒ’™ŒŒ‚É‚¨‚¯‚é”’ŒŒ‹…œ‹ŽƒtƒBƒ‹ƒ^[‚Ì“±“ü‚ɂ‚¢‚Ä. “ú–{—Տ°–ƒŒŠw‰ï‘æ38‰ñ‘å‰ï; 20181103; –k‹ãB. “ú–{—Տ°–ƒŒŠw‰ïŽ. 38(6):S358.
  58. ’·’Jì‹M”V, ‘åÎ—]Žq, é“c‚³‚‚«, ¡ò@„, ŽO•”“¿Œb, ŒÜ\F„, •àV@L, ‘ºì‰ë—m. ’™ŒŒŽ®Ž©ŒÈŒŒ—AŒŒ‚É‚æ‚èd“Ä‚È•›”½‰ž‚ð‹N‚±‚µ‚½ˆê—á. ‘æ38‰ñ“ú–{—Տ°–ƒŒŠw‰ï; 20181103; –k‹ãB. “ú–{—Տ°–ƒŒŠw‰ïŽ. 38(6):S358.
  59. ûü–Ø–ƒ”ü, ¬Œ´LŽ÷, ŒÜ\F„, ‘ºì‰ë—m. p’†‚É–[ŽºƒuƒƒbƒN‚©‚çS’âŽ~‚Æ‚È‚è‘h¶‚µ‚½Ç—á. “ú–{‘h¶Šw‰ï‘æ37‰ñ‘å‰ï; 20181116; “V“¶. ‘h¶. 37(3):220.
  60. ” ú±‹M‘å, ŽO•”“¿Œb, ‰ÔŽRçŒb, ×–ì“Ö”V, ‘åÎ—]Žq, ¡ò@„, ¬Œ´LŽ÷, ŒÜ\F„, •àV@L, ‘ºì‰ë—m. –ƒŒ‰È—Տ°ŽÀK‚É‚¨‚¯‚éƒVƒ~ƒ…ƒŒ[ƒVƒ‡ƒ“‹³ˆç‚ƍ¡Œã‚̉ۑè‚ɂ‚¢‚Ä. “ú–{‘h¶Šw‰ï‘æ37‰ñ‘å‰ï; 20181117; “V“¶. ‘h¶. 37(3):241.
  61. ¬Œ´LŽ÷, Š_–ì“àq, –{“c@, –ì’n‘PŒb, ‰ÔŽRçŒb, ‘ºì‰ë—m. –ƒŒŠoÁŒã‚Ì‚Ä‚ñ‚©‚ñ”­ì‚ɑ΂µƒfƒNƒXƒƒfƒgƒ~ƒWƒ“‚ðŽg—p‚µ‚½ˆê—á. ‘æ25‰ñ“ú–{Ã–¬–ƒŒŠw‰ï; 20181208; ‘«—˜. ƒvƒƒOƒ‰ƒ€E´˜^W. 43.
  62. –ì’n‘PŒb, ¬Œ´LŽ÷, ’·’Jì‹M”V, ‰ÔŽRçŒb, ‘ºì‰ë—m. ‘Sg–ƒŒ“±“üŽžƒvƒƒ|ƒtƒH[ƒ‹Œø‰Ê•”ˆÊ”Z“x6.4ƒÊg/mL‚Å”½‰žÁŽ¸‚ð”F‚ß‚½ˆê—á. ‘æ25‰ñ“ú–{Ã–¬–ƒŒŠw‰ï; 20181208; ‘«—˜. ƒvƒƒOƒ‰ƒ€E´˜^W. 44.

ƒVƒ“ƒ|ƒWƒEƒ€
  1. ’†ì‰ë”V. ƒGƒR[‰º_ŒoƒuƒƒbƒNFˆÀ‘SAŠmŽÀ‚È•û–@‚ð“`Žö‚µ‚Ü‚·@3) ˜]ŠÔ_ŒoƒuƒƒbƒN. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ52‰ñ‘å‰ï; 20180721; “Œ‹ž. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ. 25(3):150.

‚»‚Ì‘¼
  1. ’†ì‰ë”V. BurstDRTMŽhŒƒ‚ð—p‚¢‚½Ò‘ŽhŒƒ—Ö@F–{–M‚É‚¨‚¯‚é—Տ°ŒoŒ±@1j‚ǂ̂悤‚ÈŠ³ŽÒ‚ªBurstDRTMŽhŒƒ‚ðD‚Þ‚Ì‚©H “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ï‘æ52‰ñ‘å‰ï; 20180720; “Œ‹ž. “ú–{ƒyƒCƒ“ƒNƒŠƒjƒbƒNŠw‰ïŽ. 25(3):145.
  2. ¬Œ´LŽ÷. ŽüpŠúŠÇ—ƒ`[ƒ€ƒZƒ~ƒi[@ŽüpŠú‚ÌŒŒðÇ‚ƍRŒŒð—Ö@iÃ–¬Œn‚𒆐S‚Ɂj. “ú–{–ƒŒ‰ÈŠw‰ï–kŠC“¹E“Œ–kŽx•”‘æ8‰ñŠwpW‰ï; 20180901; ˆ®ì.
  3. ¬Œ´LŽ÷. ¬Ž™‚Ì–ò•¨“®‘Ô. “ú–{–ƒŒ‰ÈŠw‰ï–kŠC“¹E“Œ–kŽx•”‘æ8‰ñŠwpW‰ï; 20180901; ˆ®ì. ƒvƒƒOƒ‰ƒ€W. 31.
  4. ” ú±‹M‘å. ‹¤ÃƒZƒ~ƒi[ 4 ŒÄ‹z‚ÌŠî‘b`¡Œã‰ðŒˆ‚·‚é‚ׂ«‰Û‘è`. ‘æ5‰ñ–kŠC“¹E“Œ–k—Տ°HŠw‰ï; 20181007; ŒSŽR. ƒvƒƒOƒ‰ƒ€E´˜^W. 7.
  5. ¬Œ´LŽ÷. TIVAƒnƒ“ƒYƒIƒ“ƒZƒ~ƒi[. ‘æ25‰ñ“ú–{Ã–¬–ƒŒŠw‰ï; 20181208; ‘«—˜. ƒvƒƒOƒ‰ƒ€E´˜^W. 18.
  6. ¬Œ´LŽ÷. ŽüpŠúŠÇ—ƒ`[ƒ€ƒZƒ~ƒi[@ŽüpŠú‚ÌŒŒðÇ‚ƍRŒŒð—Ö@iÃ–¬Œn‚𒆐S‚Ɂj. “ú–{–ƒŒ‰ÈŠw‰ï“ŒŠCE–k—¤Žx•”‘æ16‰ñ‡“¯ŠwpW‰ï; 20180908; ‹à‘ò.


SITE MAP XV—š—𠃊ƒ“ƒNW CONTACT US
Department of Anesthesiology Fukushima Medical University. All Rights Reserved.